Stonepine Capital Management »

Abbott Laboratories shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Abbott Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Abbott Laboratories held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbott Laboratories by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 40k 95.00

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Abbott Laboratories

BlackRock
Vanguard Capital Management
State Street Corporation
Capital Research Global Investors
Vanguard Portfolio Management
Charles Schwab Investment Management
Geode Capital Management
Capital Research and Management Company - Division 3
Morgan Stanley
Wellington Management Company
Franklin Resources
Northern Trust
Bank of America Corporation
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding Abbott Laboratories